Home

Michael Greiner

CIK 1520392 · Former Interim CEO · last filed 2025-05-14

Michael Greiner is a Former Interim CEO who has filed 47 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing shows the insider had shares withheld for taxes covering $301.4K of AVNS on May 14, 2025. Across all open-market trades the lifetime net is −$492.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $67.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$67.4K

Companies

4

Total Filings

47

Lifetime Open-Market Net

-$492.8K

Filer Profile

Reported Address
C/O VISTAPRINT
95 HAYDEN AVENUE
LEXINGTON, MA 02421
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVANOS MEDICAL, INC. (AVNS) Delisted Former Interim CEO 204,493 $24.99 $5.11M -$153.0K 18 2025-05-14
ANGIODYNAMICS INC (ANGO.V) Delisted EVP and CFO 33,438 — — -$41.7K 11 2019-10-18
CMPR Sr. VP Corp Finance and CAO 771 $87.45 $67.4K $0 1 2014-11-18
CIMPRESS plc (VPRT) Delisted Sr. VP Corp Finance and CAO 625 — — -$298.1K 16 2014-08-19

Recent Filings

47 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-05-14 AVANOS MEDICAL, INC. (AVNS) Delisted Tax (F) −24,245 -$301.4K EDGAR
2025-03-11 AVANOS MEDICAL, INC. (AVNS) Delisted Grant (A) +34,316 $0 EDGAR
2025-03-10 AVANOS MEDICAL, INC. (AVNS) Delisted Tax (F) −13,597 -$208.0K EDGAR
2025-03-06 AVANOS MEDICAL, INC. (AVNS) Delisted Mixed +1,459 -$161.7K EDGAR
2024-12-05 AVANOS MEDICAL, INC. (AVNS) Delisted Grant (A) +10,000 $0 EDGAR
2024-10-31 AVANOS MEDICAL, INC. (AVNS) Delisted Grant (A) +44,189 $0 EDGAR
2024-03-19 AVANOS MEDICAL, INC. (AVNS) Delisted Mixed −4,786 -$171.9K EDGAR
2024-03-15 AVANOS MEDICAL, INC. (AVNS) Delisted Sell (S) −8,000 -$153.0K EDGAR
2024-03-14 AVANOS MEDICAL, INC. (AVNS) Delisted Notice (144) −8,000 -$153.0K EDGAR
2024-03-07 AVANOS MEDICAL, INC. (AVNS) Delisted Mixed +52,353 $1.00M EDGAR
Showing 1–10 of 47
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.